In-vitro Studies of Anti-EGFR Tyrosine Kinase Activity of Thai nutraceutical Plants

authors:

avatar Suwanna Semsri a , avatar Chanyatorn seatew b , avatar Siriluk Rattanabunyong c , avatar Sirigade Ruekit c , avatar Natharinee Horata a , avatar Aussara Panya d , e , avatar Pa-thai Yenchitsomanus d , avatar Orathai Sawatdichaikul f , * , avatar Kiattawee Choowongkomon c , g , *

Faculty of Medical Ttechnology, Huachiew Chalermprakiet University, Samut Prakarn 10540, Thailand.
Interdisciplinary Graduated Program in Genetic Engineering, Graduate School, Kasetsart University, Chatuchak, Bangkok 10900, Thailand.
Department of Biochemistry, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan Rd, Chatuchak, Bangkok 10900, Thailand.
Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Department of Nutrition and Health, Institute of Food Research and Product Development, Kasetsart University, 50 Ngam Wong Wan Rd, Chatuchak, Bangkok 10900, Thailand.
Center for Advanced Studies in Tropical Natural Resources, NRU-KU, Kasetsart University, Chatuchak, Bangkok, 10900, Thailand.
Corresponding Authors:

how to cite: Semsri S, seatew C, Rattanabunyong S, Ruekit S, Horata N, et al. In-vitro Studies of Anti-EGFR Tyrosine Kinase Activity of Thai nutraceutical Plants. Iran J Pharm Res. 2020;19(2):e127495. https://doi.org/10.22037/ijpr.2017.2022.

Abstract

Functional foods have emerged as a new approach to improve human health in term of nutraceutical to prevent people from illness rather than cure patients through medical treatment. In Asian society, particularly in Thailand, the utilizations of functional ingredients have been integrated in every parts of ordinary life. In this study, the tyrosine kinase activity of epidermal growth factor receptor (EGFR) inhibiting properties of 23 Thai’s herbs-ethanol extracts have been examined. The crude extracts of only four species that inhibit the activity of EGFR-tyrosine kinase, Azadirachta indica (neem, Sa-dao), Brucea javanica (L.) Merr. (Rajadad), Hibiscus sabdariffa L. (Roselle, Krachiap daeng), and Saccharum chinensis Roxb. (Red sugar cane). Moreover, only ethanol extractions from A. indica and B. javanica were also showed antitumor effect to non-small cell lung cancer, A549 cells.

Introductions

Epidermal growth factor receptor (EGFR, ErbB) and its related proteins (ErbB2, ErbB3, and ErbB4) in ErbB family, share both structures and functions. They hold the crucial roles in cell regulations. In addition, they are also relevant to cancer pathogenesis. Unsurprisingly, proteins in this family are popular rational targets for therapeutic intervention (1). Furthermore, aberrant activity of EGFR is observed more than 60% of patients with non-small cell lung cancer (NSCLC), the largest subset of lung cancer and the major cause of cancer death (2). Several reasons as mentioned, therefore, the EGFR protein has been emphasized in various research fields, especially in cancer research area. A number of strategies influencing this receptor, and its downstream signal cascades, including monoclonal antibodies, small molecule tyrosine kinase inhibitors, antisense oligonucleotides inhibiting EGFR synthesis and antibody-based immunoconjugates, have been evaluated. Among various types of EGFR inhibiting agents, small molecule tyrosine kinase inhibitor is established clinical activity and regulatory approval for the treatment of cancer. The anti-cancer drugs, gefitinib (Irressa® Astra Zeneca), erlotinib (Tarceva® Genetech), lapatinib (Tykerb® GlaxoSmithKline), and vandetanib (Astra Zeneca) have been approved to use for non-small cell lung cancer (NSCLC) treatment in 2003 (gefitinib) and 2004 (erlotinib), breast cancer in 2007 (lapatinib) and thyroid cancer in 2011 (vandetanib), respectively. Moreover, many of them, pelitinib, neratinib, and afatinib are under investigation both in clinical trial phase I to III, and enzymatic assay.

Even though the modern medicines are very successful in past decades, the alternative medicines that endowed with the naturally attitude are still popular (wildly used). Currently, people pay attention to phytonutrients as “nutraceutical” which provides health and medical benefits with the new concept from a food and food product. Generally, folk or local food (slow cooking) contains many natural compounds, which not only cure but also prevent from suffering some symptoms (or diseases) and promote health. This motivates the research to look for the more effective EGFR tyrosine kinase inhibitors from natural products for using in the cancer treatment and preventing. That is why people today look back into the ways of nature. Furthermore, there are tons of scientific studies report about the properties of natural product of phytonutrient in several chronic diseases (3-8), endowed with our previous prediction of the potent compounds from herbs inhibit the kinase domain of epidermal growth factor receptor, EGFR-TK (9).

This present study therefore investigated inhibitory effects of crude extracts from a set of medicinal herbs against EGFR-TK activity both enzymatic inhibition and cell line toxicity studies. The known anti-EGFR-TK drug, gefitinib was included in this study as the positive control. Dimethyl sulfoxide (DMSO), the chemical solvent, was used as the negative control.

Methods

Preparation of plant materials

Twenty-three Thai’s medicinal plants were purchased from a folk-medicinal store in Bangkok, Thailand. Scientific and Thai local names as well as the used part (s) of medicinal plants are showed in Table 1. All of dried plant materials were extracted successfully by 95% ethanol. 100 g of each plant material was soaked with 500 mL of 95% ethanol in Erlenmeyer flask with covered lid for 72 h at room temperature. Then, each supernatant was filtered with 10 nm Whatman filter paper. The filtrate was concentrated by a rotary evaporator under 50 °C. The evaporated weights of each sample were recorded. Each extract was dissolved in 95% ethanol to produce a stock solution at concentration 20 mg/mL and then, they were kept at -20 ºC until further require.

The extract yield (%w/w) was determined from all extracts by using the formular:

Yield (%)=The weight of evaporated extractThe weight of dried plant×100

Equ.1

The extractions of crude herbs by ethanol were diluted to 6 mg/mL in 1X kinase buffer (50 mM Tris-HCl, 20 mM MgCl2, 1 mM EGTA, 0.01% Brij 35, pH 7.5) containing 2 mM DTT. The crude extracts were kept at 4 °C prior to use.

Tyrosine kinase inhibition assay

Kinase domain of EGFR, active, was purchased from Millipore Corporation, Billerica, MA, USA. Measurements of tyrosine kinase inhibition assay by using fluorescence were performed as its descriptions. The procedures contain following steps; (i) enzyme-ligand incubation; 12.5 µL of 12 nM tyrosine kinase enzyme were incubated with 12.5 µL of 100 µg/mL each herbal extracted sample at room temperature for 5 min. (ii) Anti-phosphotyrosine fluorescein coupling reaction; 20 µL of antibody Beacon detection complex (6.67 nM Anti-phosphotyrosine antibody, 3.3 nM Oregon Green 488 ligand, 0.027 mg/mL poly (Glu:Tyr)) were added into pre-incubated enzyme with each herbal extracted sample. The mixed solutions were incubated at room temperature absent of light for 10 min. (iii) The activation and monitoring the reactions, each reaction was started via adding 30 µL of 1.25 mM ATP. The signal has been measured by using a fluorescence microplate reader (Tecan, Infinite F200 PRO) with excitation and emission wavelength of 485 and 530 nm, respectively. Three independent experiments have been performed.

Table

Fifty percent inhibitory concentration (IC50 ) determinations

Crude herbal extracts from 95% ethanol were diluted in two-folded dilutions with starting concentration of 4000 µg/mL to final concentration of 7.8 µg/mL. The activity of each extract towards EGFR-TK was investigated by IC50 measurements using the same protocol of TK assay as described in previous part. Subsequently, each reaction was activated, and the signal was monitored as mentioned in previous method. Nonlinear regression dose-response curves were plotted against activity and log value of inhibitor’s concentration. The GraphPad Prism program (GraphPad Software Inc., San Diego, CA, USA) has been performed to calculate the fifty percent inhibitions (IC50) of each sample.

Cell culture

In this study, two types of cell lines were used to investigate the effect of crude extracts. First, the peripheral blood mononuclear cells (PBMC) were used as a representative of normal human cell. Second, A549 cells are adenocarcinomic human alveolar basal epithelial cells, which overexpress EGFR. PBMC cells were isolated from whole blood, which was obtained from healthy people, by density gradient centrifugation using Lymphoprep (Axis-shield, UK). PBMC Cells were seeded into 96 well tissue culture plates with 1x105 cells per 100 µL of media in each well. A549 cells were cultured at 37 °C, 5% CO2 incubator in Dulbecco’s Modification of Eagle’s Medium (DMEM) with L-glutamine supplemented with 10% fetal calf serum (FCS), 1× non-essential amino acids (NEAA), 1 mM sodium pyruvate and antibiotic (100 µg/mL penicillin and 10 µg/mL streptomycin) (Gibco, USA). A549 were seeded in 96-well plate at 1.5 x104 cells/well in growth media to achieve 80% confluence.

Cell viability assay (MTT assay)

After the cultivation of PBMC cells and A549 cell lines, the crude herbal extracts were processed as described by (10). The cultured plates were incubated overnight. The cytotoxicity of herb extracts on PBMC was detected by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay (Sigma-Aldrich, MO, USA) as described previously (11).

Percentage of inhibitory from ethanol extracted herbal
Diagram of IC50 of 95% ethanol crude extracts from 5 Thai medicinal plants to EGFR-TK
Table 1

Selected Thai medicinal plants, the parts used, 95% ethanol extraction yields

No.Scientific NamePart UsedYield (%)Thai's nameCommon name
95% Ethanol    
1Allium sativum L.Bulb0.997Kra thiamGarlic
2Ananas bracteatus Schult. f.Fruit bark49.240Supparod
3Azadirachta indica* Leaves5.382Sa-daoNeem Tree
4Brucea javanica (L.) Merr.*Fruit4.919Rajadad 
5Citrus hystrix DC.Fruit bark28.050Ma-Grude 
6Citrus maxima (Burm.f.) Merr.Fruit bark2.170 Pomelo, Shaddock
7Citrus reticulata BlancoFruit bark17.465 Mandarin orange, Tagerine orange
8Diospyros mollis Griff.Stem16.983Ma-Glear 
9Eurycoma longifolia JackStem2.649Pla lai phueak (Central) 
10Hibiscus sabdariffa L.*Flower16.887Krachiap daengRoselle, Jamaican Sorrel
11Hygrophila erecta (Burm.f.) Hochr.Stem8.072Toi-ting 
12Maclura cochinchinensis (Lour.) CornerStem14.232  
13Moringa oleifera Lam.Seed2.997Ma-rumHorse radish tree
14Myristica fragrans Stem8.010JannteadNutmeg Tree
15Ocimum basilicum L.Leaves12.458Horaphaa (General)Sweet Basil
16Ociemum Sanctum L.Leaves15.829Kraprao-daengHoly Basil, Tulsi, Tulasi, Kemangen.
17Plumbago indica L.Root20.033Chetta mun phloeng daeng 
18Rhinacanthus nasutus Aerial part6.307Thong pun chung 
19Saccharum chinensis Roxb.*Stem2.035AoidangRed sugar cane
20Shirakiopsis indica (Willd.) EsserFruit1.267Samor tale 
21Spondias pinnata (L.f.) KurzFruit3.352Ma kok 
22Strychnos nux-vomica Seed1.329Salang Jaisnake wood
23Vitex trifolia L.Root5.705Khon thi so   
Table 2

IC50 values of 5 Thai's medicinal plants against tyrosine kinase activity of EGFR

NameIC50 (Mean ± SEM)
(µg/mL)
Azadirachta indica207.7 ± 9.247
Brucea javanica (L.) Merr.369.9 ± 4.856
Hibiscus sabdariffa L.1477 ± 7.129
Saccharum chinensis Rob.1270 ± 2.555
Table 3

Antiproliferative activity of 4 Thai edible herbs extract on A549 cell line expressed as IC50a (µg/mL) values

NameIC50 (Mean ± SEM)P value
 (µg/mL) 
Azadirachata indica78.6 ± 3.1P < 0.05
Brucea javanica (L.) Merr.19.8 ± 1.2P < 0.05
Saccharum chinensis Roxb.>1000P > 0.05
Hibiscus sabdariffa L.>1000P > 0.05

Results and Discussion

Effects of crude extract of edible herbs on the activity of EGFR-TK

Twenty three kinds of edible herbs are collected from traditional pharmacies (medicinal herb shop) as well as local markets around Bangkok, Thailand. In Asian countries, particularly South-east Asia, these plants are ordinary used as ingredient in not only the traditional remedies but also in cuisines. These Thai’s edible plants are consumed as the vegetables along with chili paste, juices, or as ingredients in the various kinds of soups and other fantastic Thai’s dishes, both foods and sweets including beverages. Since there are abundant of phytochemical compounds accumulating in parts of these phytonutrient-herbs, the local Thai dished also provide plenty of nutraceutical to strengthen people health. In this study, we aimed to investigate the inhibitory effects of the 95% ethanol extracts from edible herbs against activity of EGFR-TK. All details of each sample which describing scientific name, common name, local name, part of used, and % yield extracts were elucidated in Table 1. In order to examine the ability of all crude extracts to inhibit the EGFR-TK enzyme activity, tyrosine kinase inhibitory assay has been performed. The results of these observations were reported in term of relative percent inhibition values as present in the bar graph (Figure 1). The EGFR-TK known inhibitor, gefitinib (at concentration 3 µM) was used as the positive control in this screening. Four species from all twenty-three Thai’s edible herbs, present the relative percent inhibition values against EGFR-TK higher than others. Those herbs are Azadirachta indica (neem, Sa-dao), Brucea javanica (L.) Merr. (Rajadad), Hibiscus sabdariffa L. (Roselle, Krachiap daeng), and Saccharum chinensis Roxb. (Red sugar cane). Nevertheless, other herbs possessed slightly inhibitory activities against enzyme tyrosine kinase of EGFR. Surprisingly, the extracts of general edible plants that were believed to present many nutraceutical properties such as garlic (A. sativum L.), pine-apple (A. bracteatus Schult. f.) kinds of oranges (C. maxima (Brm.f.) Merr and C. reticulate Blanco) and from other two local regional species M. cochinchinensis (Lour.) Corner, and S. indica (Willd.) Esser, lacked of effect to the activity of the kinase enzyme of EGFR. The second group, nutrient plants possessed moderate inhibitory activities on EGFR-TK composed of kaffir lime (C. hystrix DC), Toi-ting (H. erecta (Burm.f.) Hochr.), horse radish tree (M. oleifera Lam.), sweet basil (O. basilicum L.), and Khon-thi-so (V. trifolia L.). In addition, the mild effects on the kinase domain of EGFR consist of seven species, which are the rest species reported in Figure 1.

According to the relative percent inhibition values of these, in particular four plants, for further precision fifty percent inhibitory concentration (IC50) determinations of EGFR-TK activity have been performed. The activity of tyrosine kinase enzyme versus log concentration of each extracts presented in Figure 2 and concluded the values in Table 2. These data indicated that the crude extracts from A. indica and B. javanica possessed the abilities to inhibit EGFR-TK better than from H. sabdariffa and S. chinensis in range of 3 to 7 folds. Notably, the crude extracts from these two latter did not significantly inhibit EGFR-TK as illustrated in the relative percent inhibition.

The cytotoxicity and viability of crude extracts to the NSCLC and normal cells

To examine the efficiency of these crude samples could inhibit the viability of lung cancer cell lines; the MTT assay was performed on adenocarcinomic human alveolar basal epithelial cells (A549). The A549 cell line is the representative of the non-small cell lung cancer type, which showed overexpression of EGFR and is sensitive to EGFR inhibitors. Our results indicated that both crude extracts from A. indica and B. javanica showed lower IC50 against A549 than H. sabdariffa and S. chinensis which lacked of inhibiting activity on the A549 cell line at our tested concentration (Table 3). In particular, the crude extract from B. javanica presented inhibitory effect on EGFR-TK stronger than from A. indica about 4 times (Table 3).

Moreover, to confirm the cytotoxicity effects of four extracted solutes to normal human cells, peripheral blood mononuclear cells (PBMC) have been cultured to evaluate these crudes (Supplementary Figure 1). The results of toxicity test indicated that the crude extracts of all four herbs were no affect to normal cells at the effective concentration against cancer cells. Interestingly, the extracts of both A. indica and B. javanica, are generally known to have anti-cancer activities (4, 12-14). In addition, parts of these two plants are ingredients of the traditional medicine remedies in several countries. The crude samples of these two mentioned plants presented the potential to inhibit the viability of the NSCLC cells and slightly affect to the cytotoxicity of the normal cells (PBMC). The extracted samples of other two species, generally consumed as juice, showed no effects both A549 and PBMC cells. B. javanica and A. india were used for traditional medicine to treat malaria, dysentery and cancer (15, 16). This study showed neither B. javanica nor A. india had any effect on PBMC, normal cell.

Plants are plenty of chemo-preventive agents that show anti-carcinogenic properties to inhibit cancer cells. Several commercial cancer drugs are developed from this source. These reasons, therefore, emphasized the intense interest on medicinal herbs for finding promising anti-cancer drug. Several researches have tried to find anti-cancer against cancer cells line without focusing on mechanism of this inhibition. Recently, Wang et Al. have tested crude extracts of Chinese herbs against EGFR-kinase (17). The five ethyl acetate extracts, Artemisia argyi, Lonicera macranthoides, Spatholobus suberectus, Curcuma longa, and Galla chinensis, and the ethanol extract of Eriobotrya japonica possessed EGFR inhibitory activities.

Four selected plants are tropical tree, shrub, ivy, and herbaceous plant, which commonly found in South and South-East Asia, including Thailand. These plants are ingredients of everyday food in Asian society. A indica (Sa-dao or neem) is generally serve accompany with chili paste in the food set. Furthermore, the result of this investigation is also corresponds with our previous computational studied (9) that the crude extracted from Azadirachata indica possesses high inhibitory activity to kinase domain of EGFR. More than sixty active compounds from neem have been identified which is isolated from all over parts of neem, leaves, stem, bark, and root. At least two active compounds, 1,3-diacetylvilasinin (18) and 28-deoxonimbolide (19) exhibited the cytotoxicity against NSCLC cells, human prostate (PC-3), pancreatic (PACA-2) cell and HL60 leukemia cells in µM range.

Brucea javanica (Rajadad) is used in various recipes, in Thai, use dried fruit to reduce phlegm, nourishing bile and cure Tan Sang toxic. Furthermore, in Chawa; Indonesia, seed of B. javanica is used for the treatment of intestinal diseases. In Philippines, fresh fruit is used to cure stomachache while in China, B. javanica is known as chelation worms in the stomach and cure dysentery. The common compounds found in B. javanica are classified in the group of brucamarine. The phytochemical from B. javanica is spotted light, according to it has shown impressive efficacy for treating various diseases including cancer. Bruceine D, a quassinoid compound extracted from B. javanica, showed anticancer effect against NSCLC and pancreatic cancer cells, besides bruceanols D, E and F exhibited cytotoxicity against various types of human cancers, malignant melanoma (RPMI-7951), lung carcinoma (A-549), ileocecal adenocarcinoma (HCT-8), epidermoid carcinoma of the nasopharynx (KB), and medulloblastoma (TE-671), and against murine lymphocytic leukemia (P-388) (13, 14, 20, 21).

From these results, there are two distinguish herbs showed the inhibitory activity to the A549 cancer cell line, which are the crude extract from B. javanica and A. indica. Nevertheless, the other two nutraceutical herbs, H. sabdariffa and S. chinensis lacked of the inhibitory effect toward NSCLC, A549 cancer cell even though they showed the strong inhibitory activity against EGFR-TK. The phytochemical compounds of these two latter herbs might be able to penetrate cell membrane.

Acknowledgements

References

  • 1.

    Raben D, Bianco C, Helfrich B, Weng E, Ciardiello F, Harari P. Interference with EGFR signaling: paradigm for improving radiation response in cancer treatment. Expert Rev. Anticancer Ther. 2002;2:461-71. [PubMed ID: 12647989].

  • 2.

    Baselga J, Cortes J. Epidermal growth factor receptor pathway inhibitors. Cancer Chemother. Biol. Response Modif. 2005;22:205-23. [PubMed ID: 16110613].

  • 3.

    Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 2006;71:1397-421. [PubMed ID: 16563357].

  • 4.

    Paul R, Prasad M, Sah NK. Anticancer biology of Azadirachta indica L (neem): a mini review. Cancer Biol. Ther. 2011;12:467-76. [PubMed ID: 21743298].

  • 5.

    Obolskiy D, Pischel I, Siriwatanametanon N, Heinrich M. Garcinia mangostana L: a phytochemical and pharmacological review. Phytother. Res. 2009;23:1047-65. [PubMed ID: 19172667].

  • 6.

    Roy MK, Thalang VN, Trakoontivakorn G, Nakahara K. Mechanism of mahanine-induced apoptosis in human leukemia cells (HL-60). Biochem. Pharmacol. 2004;67:41-51. [PubMed ID: 14667927].

  • 7.

    Siriwatanametanon N, Fiebich BL, Efferth T, Prieto JM, Heinrich M. Traditionally used Thai medicinal plants: in vitro anti-inflammatory, anticancer and antioxidant activities. J. Ethnopharmacol. 2010;130:196-207. [PubMed ID: 20435130].

  • 8.

    Siriwatanametanon N, Heinrich M. The Thai medicinal plant Gynura pseudochina var hispida: chemical composition and in vitro NF-kappaB inhibitory activity. Nat. Prod. Commun. 2011;6:627-30. [PubMed ID: 21615022].

  • 9.

    Sawatdichaikul O, Hannongbua S, Sangma C, Wolschann P, Choowongkomon K. In silico screening of epidermal growth factor receptor (EGFR) in the tyrosine kinase domain through a medicinal plant compound database. J. Mol. Model. 2012;18:1241-54. [PubMed ID: 21713415].

  • 10.

    Renner L, Schwabe A, Doll S, Holtershinken M, Danicke S. Effect of rare earth elements on beef cattle growth performance, blood clinical chemical parameters and mitogen stimulated proliferation of bovine peripheral blood mononuclear cells in-vitro and ex vivo. Toxicol. Lett. 2011;201:277-84. [PubMed ID: 21256936].

  • 11.

    Anuchapreeda S, Thanarattanakorn P, Sittipreechacharn S, Chanarat P, Limtrakul P. Curcumin inhibits WT1 gene expression in human leukemic K562 cells. Acta. Pharmacol. Sin. 2006;27:360-6. [PubMed ID: 16490174].

  • 12.

    Kurimoto S, Takaishi Y, Ahmed FA, Kashiwada Y. Triterpenoids from the fruits of Azadirachta indica (Meliaceae). Fitoterapia. 2014;92:200-5. [PubMed ID: 24239747].

  • 13.

    Lau FY, Chui CH, Gambari R, Kok SH, Kan KL, Cheng GY, Wong RS, Teo IT, Cheng CH, Wan TS, Chan AS, Tang JC. Antiproliferative and apoptosis-inducing activity of Brucea javanica extract on human carcinoma cells. Int. J. Mol. Med. 2005;16:1157-62. [PubMed ID: 16273300].

  • 14.

    Lau ST, Lin ZX, Zhao M, Leung PS. Brucea javanica fruit induces cytotoxicity and apoptosis in pancreatic adenocarcinoma cell lines. Phytother. Res. 2008;22:477-86. [PubMed ID: 18386257].

  • 15.

    Murnigsih T, Subeki, Matsuura H, Takahashi K, Yamasaki M, Yamato O, Maede Y, Katakura K, Suzuki M, Kobayashi S, Chairul, Yoshihara T. Evaluation of the inhibitory activities of the extracts of Indonesian traditional medicinal plants against Plasmodium falciparum and Babesia gibsoni. J. Vet. Med. Sci. 2005;67:829-31. [PubMed ID: 16141673].

  • 16.

    Yamada K, Subeki, Nabeta K, Yamasaki M, Katakura K, Matsuura H. Isolation of antibabesial compounds from Brucea javanica, Curcuma xanthorrhiza, and Excoecaria cochinchinensis. Biosci. Biotechnol. Biochem. 2009;73:776-80. [PubMed ID: 19270401].

  • 17.

    Wang Z, Lin S, Wang D, Huang L. Anti-epidermal growth factor receptor tyrosine kinase activities of traditional Chinese medicine for cancer treatment. Eur. J. Integr. Med. 2014;6:565-70.

  • 18.

    Rogers LL, Zeng L, Kozlowski JF, Shimada H, Alali FQ, Johnson HA, McLaughlin JL. New bioactive triterpenoids from Melia volkensii. J. Nat. Prod. 1998;61:64-70. [PubMed ID: 9461654].

  • 19.

    Kikuchi T, Ishii K, Noto T, Takahashi A, Tabata K, Suzuki T, Akihisa T. Cytotoxic and apoptosis-inducing activities of limonoids from the seeds of Azadirachta indica (neem). J. Nat. Prod. 2011;74:866-70. [PubMed ID: 21381696].

  • 20.

    Liu JH, Zhao N, Zhang GJ, Yu SS, Wu LJ, Qu J, Ma SG, Chen XG, Zhang TQ, Bai J, Chen H, Fang ZF, Zhao F, Tang WB. Bioactive quassinoids from the seeds of Brucea javanica. J. Nat. Prod. 2012;75:683-8. [PubMed ID: 22506620].

  • 21.

    Imamura K, Fukamiya N, Okano M, Tagahara K, Lee KH, Bruceanols DEF. Three new cytotoxic quassinoids from Brucea antidysenterica. J. Nat. Prod. 1993;56:2091-7. [PubMed ID: 8133299].